|
ENTX Entera Bio Ltd 1638097 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-7,312,000.00 |
| Balance Sheet |
|
Current Assets
|
$18,896,000.00 |
|
Assets
|
$19,480,000.00 |
|
Current Liabilities
|
$2,104,000.00 |
|
Liabilities
|
$12,214,000.00 |
|
Equity
|
$7,266,000.00 |
|
Shares Out
|
49290233.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-6,554,000.00 |
|
Investing Cash Flow
|
$-3,000.00 |
| Market Analysis |
Market Cap
|
$158,714,550.26 |
|
Price
|
$3.22 |
|
BVPS
|
0.15 |
|
PB
|
21.47 |
|
EPS
|
0.14 |
|
FCF
|
$-6,557,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:54 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:44 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ENTX documents filed with the SEC.
ENTX Filings
Clear
